Background: Graft fixation with interference screws for anterior cruciate ligament (ACL) reconstruction is a highly successful technique. Polyether ether ketone (PEEK) is a novel thermoplastic polymer with high biocompatibility and mechanical properties that mimic native bone, and it can be imaged on computed tomography or magnetic resonance imaging (MRI) without signal flare.
As the search for the ideal material has continued, ''bioresorbable'' interference screws were theorized to solve 2 issues. First, the material is radiologically inert and thus allows for superior postoperative MRI assessment. Second, the bioresorbable screw would allow for solid fixation, without damage to the graft as it gradually resorbs and is replaced by cancellous bone. Although bioresorbable screws have been associated with good clinical outcomes and do not cause MRI signal flare, resorption has proven unreliable and complete replacement by bone rare. 5 This is largely due to the acidic nature of the materials and the hydrolytic pathway for their dissolution, resulting in bony destruction and cyst formation. 3, 19 Another option is polyether ether ketone (PEEK), a thermoplastic polymer that is widely used in spinal and maxillofacial surgery and is becoming increasingly popular in orthopaedic surgery. PEEK is chemically inert and insoluble, has a modulus of elasticity closer to human cortical bone, is compatible with MRI, and, for sterilization purposes, has high resistance to radiation. 12 When PEEK has been compared with other commonly used materials for graft fixation, there has also been no difference in tunnel widening or cyst formation. 8, 24 PEEK itself does not encourage bone ingrowth or ongrowth, but it can be reinforced with elements such as hydroxyapatite, carbon, and tricalcium phosphate, which can encourage bony incorporation. Hence, PEEK represents a stable and biocompatible material that may address the issues that are present with titanium screws, such as graft damage because of material hardness and interference with imaging.
Previous studies in human and porcine models have shown equivalent results in pullout strength between PEEK and titanium screws. 2, 20 Similarly, a study performed on dogs found that PEEK with tricalcium phosphate fixation showed bony incorporation at 6 months and was stable through biomechanical evaluation. 15 To date, the majority of the literature on the use of PEEK surgical material in live humans has come from the spinal and maxillofacial literature.
At present, there are no prospective randomized controlled trials comparing the outcomes of PEEK and titanium interference screws for ACL reconstruction. The purpose of this study was to compare titanium interference screws with novel PEEK polymer screws by randomized controlled trial. The primary outcome was patient-reported outcomes assessed with International Knee Documentation Committee (IKDC) and Lysholm scores at 2 years. Secondary outcomes included objective measures of laxity by clinical evaluation and instrumentation by KT-1000 arthrometer, incidence of graft rupture, and MRI appearance of graft integration, cyst formation, and tunnel volume. We hypothesized that there will be no difference in patient-reported outcomes, ACL graft rerupture rate, or objective outcomes between the PEEK and titanium groups. However, we suspected that the absence of signal flare from PEEK screws will allow for more accurate MRI assessment than that for titanium screws.
METHODS
A parallel 2-group randomized controlled trial was performed on 133 patients undergoing primary ACL reconstruction between September 2013 and December 2015. Patients were aged .18 years, had no concomitant ligamentous injuries to the operative knee or the contralateral knee, lived in the local metropolitan area, and gave informed consent to participate. Exclusion criteria included associated ligamentous injury to the knee, if they were seeking compensation for their injury, or if they were pregnant. This study was performed at a high-volume private orthopaedic practice in Sydney, Australia. Surgery was performed by 2 orthopaedic surgeons (L.A.P., J.P.R.) using the same technique. Ethics approval was sought and granted by a local ethics committee (St Vincent's Hospital).
Randomization was achieved by computer-generated numbers. Before commencement of the trial, envelopes were consecutively numbered from 1 to 140 with cards that contained the words ''TITANIUM RCI'' or ''PEEK RCI.'' Randomization was restricted to multitudes of 10 with a 1:1 allocation ratio by 1 researcher. On the day before surgery, an envelope was placed into the patient's file by an administrative assistant, and this was opened just before surgery by the operating surgeon. The card was then replaced inside the envelope and sealed, only to be reopened at the conclusion of the study. While the surgical operator could not be blinded to the treatment group, the patient and clinical assessors were.
All patients received 4-strand hamstring tendon autografts with tunnels prepared by a single-incision endoscopy technique and with the anteromedial portal utilized for femoral tunnel drilling. The graft was fixed at the femur and the tibia by either a PEEK RCI HA screw (Smith & Nephew) or a Titanium RCI screw (Smith & Nephew). On the femoral side, a 7 3 25-mm screw was used in all patients except 1, who received an 8 3 25-mm screw. On the tibial side, an 8 3 30-mm or 9 3 30-mm screw was used, depending on the patient's bone quality, which was assessed intraoperatively by manually gauging resistance when reaming. Patients in both groups were discharged home on the day of surgery and underwent an accelerated rehabilitation protocol, commencing formal physical therapy on postoperative day 0 for weightbearing and range of movement exercises. Return to competitive sports was prohibited until 6 to 9 months after the reconstruction and then was allowed only after rehabilitation goals had been met. Achievement of these goals was assessed by the surgeon and the physical therapist and included range of movement, strength, and agility.
Standard clinical reviews took place at 1 week, 6 weeks, and 6 months. At 12 and 24 months, subjective evaluation was performed with the Lysholm questionnaire and IKDC. Ligament stability was assessed with a full IKDC examination, including Lachman test, pivot-shift test, and KT-1000 arthrometer (MEDmetric). Assessment was performed by 2 specialist research physical therapists (E.H., L.J.S.), who were blinded to screw allocation.
MRI was performed at 1 year to evaluate graft integration, the presence of effusion or synovitis, cyst formation, and tibial and femoral tunnel volumes. MRI was performed at a single imaging center with musculoskeletal specialist MRI radiologists, and modified oblique and coronal sequences were chosen to optimize postoperative tunnel volume measurement. If patients were unable to attend the nominated imaging center, MRI was performed at alternative imaging centers, and all assessments were carried out by 1 musculoskeletal radiologist (J.P.L.), except for tunnel volume measurement. Graft integration was assessed on the femoral and tibial sides by observing the graft adjacent to the interference screw to have uniform, concentric low signal interface (''complete integration'') or focal or diffuse high signal (''incomplete integration''). 18 The modified MRI sequences were designed so that slices would be exactly perpendicular (tibial) or parallel (femoral) to the long axis of the tibial and femoral tunnels: axial imaging slices were aligned perpendicular to the tibial tunnel axis (''oblique axial''), and modified coronal (''oblique coronal'') slices were taken parallel to the femoral tunnels ( Figure 1) .
The technique of interpretation of tunnel volume was discussed with a musculoskeletal radiologist and agreed on; then, measurements were made independently by an orthopaedic surgeon and an orthopaedic registrar (S.S., M.F.) using a computer-based volume assessment tool (Inteliviewer; Intelerad Systems). For each imaging slice positioned perpendicular to the femoral or tibial tunnel, the border of the tunnel was traced with a stylus on a digital pen/tablet device (Intuos Art; Wacom) and the crosssectional area of the enclosed region calculated. Consistent brightness and contrast ratios were established (contrast/ width = 1000, brightness/length = 600) such that tunnel borders were clearly defined on 3 mm-thick proton density image slices. The tunnel cross-sectional area was calculated only if the full circumference of the tunnel was visible on that slice. By incorporating the known slice thickness, the ''volume of interest'' tool converted adjacent crosssectional areas into a total tunnel volume (mm 3 ) for the tibia and femur. The technique of measurement is novel and has not previously been reported.
This study was designed to test equivalence of PEEK screws as compared with titanium for the primary outcome variable of mean subjective IKDC score. For a level of significance of 5% and power of 80%, a sample size of 53 in each group was calculated to be required to detect a difference of 10%, based on a 1-sided test. The sample size includes 20% oversampling to allow for potential withdrawals and losses to follow-up. Statistical analysis was performed with SPSS software for Windows (v 25; IBM). Statistical significance was set at P = .05. Comparison of variables between groups was analyzed with a x 2 test for categorical data and an independent-samples t test. For data elements where a count \5 was present in a particular category, a Fisher exact test was used. Linear variables were summarized by the mean, and categorical variables were summarized by frequency. To assess interobserver reliability of MRI assessment of volumes of the femoral and tibial tunnels, the intraclass correlation coefficient (ICC) was calculated. For interpretation of the ICC, we used the subjective guidelines established by Landis and 
RESULTS
A total of 68 patients were enrolled in the PEEK group and 65 in the titanium group. At 2-year review, 64 (94%) in the PEEK group and 51 (90%) in the titanium group had complete subjective and objective evaluation. Two patients in the PEEK group and 5 in the titanium group were lost to follow-up and unable to be contacted. One patient in the titanium group withdrew from the study; the other patients did not attend follow-up or were unable to be contacted (Figure 2) . There was no statistical difference between groups for baseline demographics or injury profile (Table 1) .
There was also no significant difference between the titanium and PEEK groups in regard to operative tunnel volume and screw size. The mean femoral tunnel sizes at the time of surgery were 7.5 mm in the titanium group and 7.6 mm in the PEEK group (P = .3), and the mean tibial tunnel sizes at the time of surgery were 7.4 mm in the titanium group and 7.5 mm in the PEEK group (P = .3). There were 4 ACL graft ruptures over the 2-year period in the titanium group and none in the PEEK group (P = .054). The graft ruptures occurred at 3, 5, 9, and 24 months after surgery, and the causes were fall while intoxicated, soccer, soccer, and fall from a ladder, respectively. Contralateral ACL rupture occurred in 1 patient in both the PEEK and the titanium arms of the study.
For subjective analysis, only patients with an intact ACL in the operated knee were included. This resulted in 56 patients undergoing review in the titanium group and 66 in the PEEK group. There was no significant difference between the groups in regard to subjective outcomes (Table 2) .
Objective evaluation was performed only on patients with an intact graft and contralateral native ACL; this included 63 patients in the PEEK group (94%) and 53 in the titanium group (88%). Forty-two patients (79%) in the titanium group and 43 (68%) in the PEEK group had a normal knee according to the IKDC knee examination (P = .2). No patients had an abnormal or severely abnormal knee. There was no significant difference in regard to effusion, range of movement, functional ability, or degree of laxity based on Lachman, pivot-shift, and KT-1000 tests (Table 3) .
MRI was performed in 116 of the 133 patients (87%). Of the patients with completed MRI, 93 (70%) had the novel modified format that allowed accurate assessment of tunnel volumes. The remaining 23 patients had MRI performed at alternative imaging centers, with a standard technique. There was no significant difference between the titanium and PEEK groups in the presence of effusion, synovitis, bone edema adjacent to the tunnels, or cyst/ganglion formation. There was a significantly higher rate of complete femoral graft integration in the titanium group as compared with the PEEK group (Table 4) .
Regarding the interobserver reliability of tunnel volumes performed on postoperative MRI, the ICC was high for the PEEK screw group: 0.868 for the tibial tunnels and 0.689 for the femoral tunnels. By comparison, for the titanium screws, the ICC values were 0.768 for the tibial tunnels and 0.531 for the femoral tunnels. The tunnel volumes on the tibia measured a mean 3.5 mm 3 for the titanium group and 3.8 mm 3 for the PEEK group (P = .05). There was a significant difference in the volume of the femoral tunnels, with the titanium group measuring a mean 3.3 mm 3 as opposed to 2.8 mm 3 in the PEEK group (P = .002).
DISCUSSION
The results of this study show equivalence when comparing PEEK with titanium interference screws when used for ACL reconstruction, in regard to mean subjective IKDC and Lysholm knee scores, rerupture rate, and objective examination with IKDC ligament examination grades. Furthermore, PEEK screws did not show any difference in rates of synovitis, edema, or cyst formation on MRI versus titanium screws at 12 months.
Over the 24 months, there were no reruptures within the PEEK group. The titanium group did have 4 patients who ruptured their graft. This result nearly approached statistical significance, with a P value of .054. The graft ruptures from the titanium screw cohort occurred at 3, 5, 9, and 24 months after surgery, and the respective causes were fall while intoxicated, soccer, soccer, and fall from a ladder. It is probable that the failures were related to the nature of the mechanism of injury or ill-advised early return to sport; however, there is also concern that titanium screws may damage the graft when inserted and thus may contribute to early failure. 10 A larger cohort size may have further exposed this.
Another result that neared statistical significance was no pain with strenuous or very strenuous activity (P = .08). To determine significance of this variable would have required 70 patients in each group; thus, we are underpowered to appropriately examine this variable. Cohort size is certainly a limitation, and we are unable to conclude a difference on this variable. However, without any significant differences in examination, including effusion, range of movement, or stability, and given the fact that an equivalent number of patients returned to, at a minimum, strenuous activity, it is difficult to determine what the source of pain may be for 17% of patients in the PEEK group.
One of the benefits of PEEK is that it does not interfere with postoperative imaging on MRI. This is indicated in the superior interobserver reliability in measuring tunnel volumes for PEEK versus titanium screws. Particularly on measuring the femoral tunnels with titanium, the reliability was graded as moderate agreement per Landis and Koch criteria, 13 as opposed to substantial in the PEEK group. This is likely secondary to the degree of scatter artifact caused by metal material. A further benefit is that when compared with bioabsorbable screws, PEEK screws do not cause cysts or inflammatory change because of degradation, showing comparable results with titanium. Furthermore, in the case of revision surgery, the PEEK screw can be removed with the same ease of titanium because, unlike bioabsorbable screws, PEEK does not lose structural integrity over time.
There was a high rate of effusion identified on MRI in the titanium and PEEK groups at 76% and 67%, respectively (P = .3). Effusions were graded to be small, and the incidence of associated synovitis was relatively low, 22% and 10% for the titanium and PEEK groups, respectively. It has been reported that at 12 months, only 11% of patients will have knee joint effusion back to baseline.
14 Therefore, this rate of MRI-reported effusion may be expected at 12-month review. At clinical review at 24 months, 94% and 86% of patients in the titanium and PEEK groups, respectively, had no clinically apparent effusion.
There was a significant difference between the titanium and PEEK screw groups in regard to the proportion of patients who demonstrated incomplete graft integration on the femoral side. This finding was seen in 6 of the 61 patients (10%) in the PEEK group and none of the 55 patients from the titanium group. Incomplete integration was defined as focal or diffuse high signal in the graft adjacent to the interference screw; if this was not observed, then it was categorized as complete integration. It is likely that the difference in femoral integration is attributable to the inability to assess the graft signal in the presence of metal artifact caused by the titanium screw, despite the use of suppression software. This concept is illustrated in Figure 3 , which compares representative MRI slices from knees with titanium and PEEK screws. As shown, the graft is directly adjacent to the screw and obscured by metal artifact in the titanium screw group. There was, however, no significant difference in the rates of complete integration for the tibia. Artifact produced by metal in MRI is related to, among other things, the orientation of the implant in the magnetic field. 21 It is believed that the oblique orientation of the screw in the femoral tunnel results in a greater degree of artifact and difficulty in visualizing the graft. It is our impression that the result of incomplete integration of the graft at the femur in the Figure 3 . Comparison of magnetic resonance imaging appearance of bone adjacent to (A) a polyether ether ketone screw and (B) a titanium screw, highlighting interference phenomenon caused by metallic properties of titanium, which reduces the ability to visualize the adjacent tunnel and anterior cruciate ligament graft.
